Literature DB >> 8414152

Chronic renal failure in India.

M K Mani1.   

Abstract

In a series of 2028 patients with chronic renal failure, the diseases leading to renal failure, the presence or absence of reversible factors and their nature, and the rate of decline of renal function of the most common conditions have been described and analysed. Seven diseases: chronic interstitial nephritis (27.85%), diabetic nephropathy (26.76%), chronic glomerulonephritis (18.20%), benign nephrosclerosis (10.06%), chronic pyelonephritis (7.29%), focal glomerulosclerosis (3.20%), and autosomal dominant polycystic disease of the kidneys (2.07%), accounted for 95.43% of all the patients. These diseases were studied in greater detail and the results are presented here. It was found that there was a great variation in the rate of decline of renal function in the different groups, with chronic glomerulonephritis and focal glomerular sclerosis progressing most rapidly, diabetic nephropathy slightly slower, and the others at a less alarming pace. However, once serum creatinine had reached 177 mumol/l there was an inexorable decline in renal function and the end stage was reached in almost all patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8414152     DOI: 10.1093/ndt/8.8.684

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

Review 1.  Interstitial nephritis.

Authors:  S Dhillon; R M Higgins
Journal:  Postgrad Med J       Date:  1997-03       Impact factor: 2.401

Review 2.  Climate Change and the Emergent Epidemic of CKD from Heat Stress in Rural Communities: The Case for Heat Stress Nephropathy.

Authors:  Jason Glaser; Jay Lemery; Balaji Rajagopalan; Henry F Diaz; Ramón García-Trabanino; Gangadhar Taduri; Magdalena Madero; Mala Amarasinghe; Georgi Abraham; Sirirat Anutrakulchai; Vivekanand Jha; Peter Stenvinkel; Carlos Roncal-Jimenez; Miguel A Lanaspa; Ricardo Correa-Rotter; David Sheikh-Hamad; Emmanuel A Burdmann; Ana Andres-Hernando; Tamara Milagres; Ilana Weiss; Mehmet Kanbay; Catharina Wesseling; Laura Gabriela Sánchez-Lozada; Richard J Johnson
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-05       Impact factor: 8.237

Review 3.  Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment.

Authors:  Randy L Luciano; Mark A Perazella
Journal:  Drug Saf       Date:  2015-01       Impact factor: 5.606

4.  A Newly Recognized Endemic Region of CKD of Undetermined Etiology (CKDu) in South India-"Tondaimandalam Nephropathy".

Authors:  Sreejith Parameswaran; P Krishnankutty Rinu; Sitanshu Sekhar Kar; Kotteyen Thazhath Harichandrakumar; Thottyplackel Devassiya James; Puthenpurackal Sivan Pillai Priyamvada; Satish Haridasan; Sumit Mohan; Jai Radhakrishnan
Journal:  Kidney Int Rep       Date:  2020-09-15

5.  Dynamics of electroencephalogram (EEG) in different stages of chronic kidney disease.

Authors:  Pradyumna Gadewar; Sourya Acharya; Praveen Khairkar; Samarth Shukla; S N Mahajan
Journal:  J Clin Diagn Res       Date:  2015-03-01

6.  The high prevalence of chronic kidney disease-mineral bone disorders: A hospital-based cross-sectional study.

Authors:  B Ghosh; T Brojen; S Banerjee; N Singh; S Singh; O P Sharma; J Prakash
Journal:  Indian J Nephrol       Date:  2012-07

7.  What do we know about chronic kidney disease in India: first report of the Indian CKD registry.

Authors:  Mohan M Rajapurkar; George T John; Ashok L Kirpalani; Georgi Abraham; Sanjay K Agarwal; Alan F Almeida; Sishir Gang; Amit Gupta; Gopesh Modi; Dilip Pahari; Ramdas Pisharody; Jai Prakash; Anuradha Raman; Devinder S Rana; Raj K Sharma; R N Sahoo; Vinay Sakhuja; Ravi Raju Tatapudi; Vivekanand Jha
Journal:  BMC Nephrol       Date:  2012-03-06       Impact factor: 2.388

8.  The effect of rural-to-urban migration on renal function in an Indian population: cross-sectional data from the Hyderabad arm of the Indian Migration Study.

Authors:  Phillippa K Bailey; Charles R V Tomson; Sanjay Kinra; Shah Ebrahim; K V Radhakrishna; Hannah Kuper; Dorothea Nitsch; Yoav Ben-Shlomo
Journal:  BMC Nephrol       Date:  2013-10-31       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.